Evidence map›Paper›PMID 25537849›Full record

ReviewMedical microbiology and immunology2015

Mutational escape of CD8+ T cell epitopes: implications for prevention and therapy of persistent hepatitis virus infections.

Joerg Timm, Christopher M Walker

Abstract readReview
In one paragraph

Review in Medical microbiology and immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Frontiers in microbiology · 2024
    Article
  3. Current Trends in Neoantigen-Based Cancer Vaccines.Pharmaceuticals (Basel, Switzerland) · 2023
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Immune escape pathways from the HBV coreFrontiers in immunology · 2022
    Article
  11. CD8Frontiers in immunology · 2022
    Article
  12. Human hepatitis D virus-specific T cell epitopes.JHEP reports : innovation in hepatology · 2021
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Differential escape of HCV from CD8Journal of viral hepatitis · 2019
    Article
  18. Review
  19. Article
  20. Natural killer cells in liver diseases.Frontiers of medicine · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Joerg TimmInstitute of Virology, University Hospital Düsseldorf, Heinrich-Heine-University, Universitätsstrasse 1, 40225, Düsseldorf, Germany, joerg.timm@med.uni-duesseldorf.de.
Christopher M Walker

Funding

HCV-specific T cell responseR37AI047367 · NIAID · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI WALKER, CHRISTOPHER M. · 2005 to 2014
$6.1M
NIAID NIH HHS R37 AI047367
6 · The paper itself

Abstract

Over the past two decades, much has been learned about how human viruses evade T cell immunity to establish persistent infection. The lessons are particularly relevant to two hepatotropic viruses, HBV and HCV, that are very significant global public health problems. Although HCV and HBV are very different, the natural history of persistent infections with these viruses in humans shares some common features including failure of T cell immunity. During recent years, large sequence studies of HCV have characterized intra-host evolution as well as sequence diversity between hosts in great detail. Combined with studies of CD8+ T cell phenotype and function, it is now apparent that the T cell response shapes viral evolution. In turn, HCV sequence diversity influences the quality of the CD8+ T cell response and thus infection outcome. Here, we review published studies of CD8+ T cell selection pressure and mutational escape of the virus. Potential consequences for therapeutic strategies to restore T cell immunity against persistent human viruses, most notably HBV, are discussed.

Indexed as

Immune EvasionCD8-Positive T-LymphocytesEpitopesEvolution, MolecularHepacivirusHepatitis BHepatitis B virusHepatitis CHepatitis VirusesHumansImmunotherapyMutationEpitopes

Identifiers

PMID25537849
PMCPMC4305108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.